Abstract
Since little is known concerning regulation of immunological parameters in rapid changing psychiatric states like panic attacks, we measured cytokines at different time points in healthy subjects, which underwent experimental panic induction using the CCK-4 paradigm. Apart from a challenge related IL-6 increase, we could not observe any changes of neuroimmunological markers in relation to acute anxiety with regard to time and group. Herein we conducted for the first time a new approach to immunological research in panic disorder, suggesting immune changes are more related to long term disease stress.
Similar content being viewed by others
References
Andreoli A, Keller SE, Rabaeus M, Zaugg L, Garrone G, Taban C (1992) Immunity, major depression, and panic disorder comorbidity. Biol Psychiatry 31:896–908
Bradwejn J, Koszycki D (2001) Cholecystokinin and panic disorder: past and future clinical research strategies. Scand J Clin Lab Invest Suppl 234:19–27
Brambilla F, Bellodi L, Perna G (1999) Plasma levels of tumor necrosis factor-alpha in patients with panic disorder: effect of alprazolam therapy. Psychiatry Res 89:21–27
Brambilla F, Bellodi L, Perna G, Battaglia M, Sciuto G, Diaferia G, Petraglia F, Panerai A, Sacerdote P (1992) Psychoimmunoendocrine aspects of panic disorder. Neuropsychobiology 26:12–22
Brambilla F, Bellodi L, Perna G, Bertani A, Panerai A, Sacerdote P (1994) Plasma interleukin-1-beta plasma concentrations in panic disorder. Psychiatry Res 54:135–142
Calandra T, Bucala R (1997) Macrophage inhibitory factor: a glucocorticoid counter-regulator within the immune system. Crit Rev Immunol 17:77–88
Erhardt A, Ising M, Unschuld PG, Kern N, Lucae S, Pütz B, Uhr M, Binder EB, Holsboer F, Keck ME (2006) Regulation of the hypothalamic-pituitary-adrenocortical system in patients with panic disorder. Neuropsychopharmacology 31:2515–2522
Isidori AM, Kaltsas GA, Korbonits M, Pyle M, Gueorguiev M, Meinhardt A, Metz C, Petrovsky N, Popovic V, Bucala R, Grossman AB (2002) Response of serum macrophage migration inhibitory factor levels to stimulation or suppression of the hypothalamo-pituitary-adrenal axis in normal subjects and patients with Cushing’s disease. J Clin Endocrinol Metab 87:1834–1840
Koh KB, Lee Y (2004) Reduced anxiety levels by therapeutic interventions and cell-mediated immunity in panic disorder patients. Psychother Psychosom 73:286–292
Maes M (1999) Major depression and activation of the inflammatory response system. Adv Exp Med Biol 461:25–46
Maes M, Lin A, Delmaire L, Van Gastel A, Kenis G, De Jongh R, Bosman E (1999) Elevated serum interleukin-6 (IL-6) and IL-6 receptor concentrations in posttraumatic stress disorder after accidental man-made traumatic events. Biol Psychiatry 45:833–839
Maes M, Song C, Lin A, De Jongh R, Van Gastel A, Kenis G, Bosman E, De Meester I, Benoy I, Neels H, Demedts P, Janca A, Scharpé S, Smith RS (1998) The effect of psychological stress on humans: increased production of pro-inflammatory cytokines and a Th1-like response in stress-induced anxiety. Cytokine 10:313–318
Müller N, Hofschuster E, Ackenheil M, Mempel W, Eckstein R (1993) Investigations of the cellular immunity during depression and the free interval: evidence for an immune activation in affective psychosis. Prog Neuropsychopharmacol Biol Psychiatry 17:713–730
O’Brien SM, Scott LV, Dinan TG (2004) Cytokines: abnormalities in major depression and implications for pharmacological treatment. Hum Psychopharmacol Clin Exp 19:397–403
Rapaport MH, Stein MB (1994) Serum cytokine and soluble interleukin-2 receptors in patients with panic disorder. Anxiety 1:22–25
Smith RS (1991) The macrophage theory of depression. Med Hypotheses 35:298–306
Suarez EC, Boyle SH, Lewis JG, Hall RP, Young KH (2006) Increases in stimulated secretion of proinflammatory cytokines by blood monocytes following arousal of negative affect: the role of insulin resistance as moderator. Brain Behav Immun 20:331–338
Vgontzas AN, Bixler EO, Lin H-M, Prolo P, Trakada G, Chrousos GP (2005) IL-6 and its circadian secretion in humans. Neuroimmunomodulation 12:131–140
Webster JI, Tonelli L, Sternberg EM (2002) Neuroendocrine regulation of Immunity. Annu Rev Immunol 20:125–163
Weizman R, Laor N, Wiener Z, Wolmer L, Bessler H (1999) Cytokine production in panic disorder patients. Clin Neuropharmacol 22:107–109
Zwanzger P, Baghai TC, Schuele C, Strohle A, Padberg F, Kathmann N, Schwarz M, Möller HJ, Rupprecht R (2001) Vigabatrin decreases cholecystokinin-tetrapeptide (CCK4) induced panic in healthy volunteers. Neuropsychopharmacology 25:699–703
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
de la Fontaine, L., Schwarz, M.J., Eser, D. et al. Effects of experimentally induced panic attacks on neuroimmunological markers. J Neural Transm 116, 699–702 (2009). https://doi.org/10.1007/s00702-008-0140-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00702-008-0140-6